Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-generated health data collection using a wearable activity tracker in cancer patients-a feasibility study.
Miyaji T, Kawaguchi T, Azuma K, Suzuki S, Sano Y, Akatsu M, Torii A, Kamimura T, Ozawa Y, Tsuchida A, Eriguchi D, Hashiguchi M, Nishino M, Nishi M, Inadome Y, Yamazaki T, Kiuchi T, Yamaguchi T. Miyaji T, et al. Among authors: sano y. Support Care Cancer. 2020 Dec;28(12):5953-5961. doi: 10.1007/s00520-020-05395-z. Epub 2020 Apr 12. Support Care Cancer. 2020. PMID: 32281031
The Japanese version of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events.
Kawaguchi T, Azuma K, Sano M, Kim S, Kawahara Y, Sano Y, Shimodaira T, Ishibashi K, Miyaji T, Basch E, Yamaguchi T. Kawaguchi T, et al. Among authors: sano m, sano y. J Patient Rep Outcomes. 2017;2(1):2. doi: 10.1186/s41687-017-0022-5. Epub 2018 Jan 5. J Patient Rep Outcomes. 2017. PMID: 29757309 Free PMC article.
Randomized controlled phase III study comparing chemotherapy alone versus conversion surgery after a remarkable response to chemotherapy in patients with initially unresectable cStage IVB or pStage IV gastric cancer (JCOG2301, Conversion study).
Kita R, Yasufuku I, Takahashi N, Mizusawa J, Sano Y, Fukuda H, Kurokawa Y, Boku N, Terashima M, Yoshikawa T; Stomach Cancer Study Group of the Japan Clinical Oncology Group. Kita R, et al. Among authors: sano y. Jpn J Clin Oncol. 2024 Dec 18:hyae174. doi: 10.1093/jjco/hyae174. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39690810
Sex differences in toxicities and survival outcomes among Japanese patients with Stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of 4 randomized controlled trials (JCOG2310A).
Hirano H, Kataoka K, Yamaguchi T, Wagner AD, Shimada Y, Inomata M, Hamaguchi T, Takii Y, Mizusawa J, Sano Y, Shiomi A, Shiozawa M, Ohue M, Adachi T, Ueno H, Ikeda S, Komori K, Tsukamoto S, Takashima A, Kanemitsu Y. Hirano H, et al. Among authors: sano y. Eur J Cancer. 2025 Jan;214:115139. doi: 10.1016/j.ejca.2024.115139. Epub 2024 Nov 19. Eur J Cancer. 2025. PMID: 39579641
1,917 results